Walgreens Boots Alliance (WBA) Receiving Somewhat Favorable Press Coverage, Analysis Finds
Media headlines about Walgreens Boots Alliance (NASDAQ:WBA) have trended somewhat positive this week, according to Accern. The research firm identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Walgreens Boots Alliance earned a daily sentiment score of 0.11 on Accern’s scale. Accern also assigned media headlines about the pharmacy operator an impact score of 46.5633257183736 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
These are some of the media headlines that may have impacted Accern Sentiment Analysis’s scoring:
- Walgreens Boots Alliance, Inc. (WBA) Stake Maintained by Shufro Rose & Co. LLC (overnewsmagazine.com)
- Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Bought by Savant Capital LLC (campdesrecrues.com)
- CVS Health Still On Way Back To ‘Healthy Growth,’ CEO Says (finance.yahoo.com)
- CVS Health CEO Doubts Amazon Entry Into Pharmacy (finance.yahoo.com)
- Volume Moving the Tape For Walgreens Boots Alliance Inc (WBA) – Evergreen Caller (evergreencaller.com)
Shares of Walgreens Boots Alliance (WBA) traded up 0.25% on Wednesday, hitting $81.28. The company had a trading volume of 5,261,270 shares. The company has a 50 day moving average price of $78.70 and a 200 day moving average price of $82.37. Walgreens Boots Alliance has a 1-year low of $75.18 and a 1-year high of $89.69. The firm has a market capitalization of $86.98 billion, a price-to-earnings ratio of 20.53 and a beta of 1.25.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.30 by $0.03. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The company had revenue of $30.12 billion for the quarter, compared to analyst estimates of $29.72 billion. During the same period in the previous year, the company posted $1.18 EPS. The firm’s revenue for the quarter was up 2.1% compared to the same quarter last year. On average, equities analysts forecast that Walgreens Boots Alliance will post $5.01 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 12th. Investors of record on Friday, August 18th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.97%. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. The ex-dividend date is Wednesday, August 16th. Walgreens Boots Alliance’s payout ratio is presently 37.78%.
Walgreens Boots Alliance announced that its board has initiated a share repurchase plan on Thursday, June 29th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to repurchase up to 5.9% of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s board believes its stock is undervalued.
Several research firms have recently commented on WBA. Leerink Swann set a $90.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Tuesday, April 11th. Zacks Investment Research downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Wednesday, June 14th. BidaskClub raised Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Thursday, August 3rd. Jefferies Group LLC dropped their price target on Walgreens Boots Alliance from $95.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, May 31st. Finally, Needham & Company LLC set a $94.00 price target on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Monday, July 17th. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and fourteen have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $90.69.
COPYRIGHT VIOLATION NOTICE: “Walgreens Boots Alliance (WBA) Receiving Somewhat Favorable Press Coverage, Analysis Finds” was reported by Watch List News and is owned by of Watch List News. If you are reading this news story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this news story can be read at https://www.watchlistnews.com/walgreens-boots-alliance-wba-receiving-somewhat-favorable-press-coverage-analysis-finds/1466560.html.
In related news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total transaction of $218,305.44. Following the sale, the director now directly owns 19,151 shares in the company, valued at approximately $1,528,058.29. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 13.50% of the company’s stock.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.